Literature DB >> 25797046

PCNA-interacting peptides reduce Akt phosphorylation and TLR-mediated cytokine secretion suggesting a role of PCNA in cellular signaling.

Camilla Olaisen1, Rebekka Müller1, Aina Nedal1, Marit Otterlei2.   

Abstract

Proliferating cell nuclear antigen (PCNA), commonly known as a nuclear protein essential for regulation of DNA replication, DNA repair, and epigenetics, has recently been associated with multiple cytosolic functions. Many proteins containing one of the two known PCNA-interacting motifs, the AlkB homologue 2 PCNA interacting motif (APIM) and the PCNA-interacting peptide (PIP)-box, are considered to be mainly cytosolic. APIM is found in more than 20 kinases and/or associated proteins including several direct or indirect members of the mitogen-activated protein kinase (MAPK) and PI3K/Akt pathways. Mass spectrometry analysis of PCNA-pull downs verified that many cytosolic proteins involved in the MAPK and PI3K/Akt pathways are in complex with PCNA. Furthermore, treatment of cells with a PCNA-interacting APIM-containing peptide (APIM-peptide) reduced Akt phosphorylation in human peripheral blood monocytes and a human keratinocyte cell line (HaCaT). Additionally, the APIM-peptide strongly reduced the cytokine secretion from monocytes stimulated with toll like receptor (TLR) ligands and potentiated the effects of MAPK and PI3K/Akt inhibitors. Interestingly, the protein level of the APIM-containing PKR/RIG-1 activator protein (PACT) was initially strongly reduced in HaCaT cells stimulated with APIM-peptide in combination with the TLR ligand polyinosinic-polycytidylic acid (polyIC). Our results suggest that PCNA has a platform role in cytosol affecting cellular signaling.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  APIM; MAPK; PCNA; PI3K/Akt; TLR

Mesh:

Substances:

Year:  2015        PMID: 25797046     DOI: 10.1016/j.cellsig.2015.03.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  19 in total

Review 1.  Forging Ahead through Darkness: PCNA, Still the Principal Conductor at the Replication Fork.

Authors:  Katherine N Choe; George-Lucian Moldovan
Journal:  Mol Cell       Date:  2017-02-02       Impact factor: 17.970

2.  Structure of proliferating cell nuclear antigen (PCNA) bound to an APIM peptide reveals the universality of PCNA interaction.

Authors:  Kodai Hara; Masayuki Uchida; Risa Tagata; Hideshi Yokoyama; Yoshinobu Ishikawa; Asami Hishiki; Hiroshi Hashimoto
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-03-22       Impact factor: 1.056

3.  Anti-Cancer Potential of Homemade Fresh Garlic Extract Is Related to Increased Endoplasmic Reticulum Stress.

Authors:  Voin Petrovic; Anala Nepal; Camilla Olaisen; Siri Bachke; Jonathan Hira; Caroline K Søgaard; Lisa M Røst; Kristine Misund; Trygve Andreassen; Torun M Melø; Zdenka Bartsova; Per Bruheim; Marit Otterlei
Journal:  Nutrients       Date:  2018-04-05       Impact factor: 5.717

4.  NKp44-Derived Peptide Binds Proliferating Cell Nuclear Antigen and Mediates Tumor Cell Death.

Authors:  Avishai Shemesh; Kiran Kundu; Refael Peleg; Rami Yossef; Irena Kaplanov; Susmita Ghosh; Yana Khrapunsky; Orly Gershoni-Yahalom; Tatiana Rabinski; Adelheid Cerwenka; Roee Atlas; Angel Porgador
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

5.  The role of PCNA as a scaffold protein in cellular signaling is functionally conserved between yeast and humans.

Authors:  Camilla Olaisen; Hans Fredrik N Kvitvang; Sungmin Lee; Eivind Almaas; Per Bruheim; Finn Drabløs; Marit Otterlei
Journal:  FEBS Open Bio       Date:  2018-05-31       Impact factor: 2.693

6.  Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.

Authors:  Salim F A Jeddo; Xianfu Wei; Ka Li; Xin Li; Qiang Yang; Samina Dongol; Jianmin Li
Journal:  Oncol Rep       Date:  2020-07-13       Impact factor: 3.906

7.  "Two hits - one stone"; increased efficacy of cisplatin-based therapies by targeting PCNA's role in both DNA repair and cellular signaling.

Authors:  Caroline Krogh Søgaard; Augun Blindheim; Lisa M Røst; Voin Petrović; Anala Nepal; Siri Bachke; Nina-Beate Liabakk; Odrun A Gederaas; Trond Viset; Carl-Jørgen Arum; Per Bruheim; Marit Otterlei
Journal:  Oncotarget       Date:  2018-08-21

8.  Co-occurrence of opisthorchiasis and diabetes exacerbates morbidity of the hepatobiliary tract disease.

Authors:  Apisit Chaidee; Sudarat Onsurathum; Kitti Intuyod; Patchareewan Pannangpetch; Chatlert Pongchaiyakul; Porntip Pinlaor; Chawalit Pairojkul; Wannaporn Ittiprasert; Christina J Cochran; Victoria H Mann; Paul J Brindley; Somchai Pinlaor
Journal:  PLoS Negl Trop Dis       Date:  2018-06-28

9.  Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.

Authors:  Yujing Gao; Hongning Ma; Chanchan Gao; Ye Lv; XueHua Chen; Rongrong Xu; Miao Sun; Xinrui Liu; Xiaohong Lu; Xiuying Pei; Pu Li
Journal:  J Transl Med       Date:  2018-02-23       Impact factor: 5.531

10.  APIM-peptide targeting PCNA improves the efficacy of docetaxel treatment in the TRAMP mouse model of prostate cancer.

Authors:  Caroline K Søgaard; Siver A Moestue; Morten B Rye; Jana Kim; Anala Nepal; Nina-Beate Liabakk; Siri Bachke; Tone F Bathen; Marit Otterlei; Deborah K Hill
Journal:  Oncotarget       Date:  2018-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.